W
Waycen
AI-powered software for real-time endoscopic image analysis
About Waycen
Founded in 2019 by CEO Kyungnam Kim, Waycen is a medical AI company specializing in solutions for the entire cancer lifecycle. Kim, who has an engineering background from KAIST and POSTECH, previously held management roles at Samsung Electronics and Telson before serving as CEO of SELVAS AI. He established Waycen with a team of developers who have worked with him for over a decade.
The company's core product is WAYMED Endo, an AI-powered software that analyzes endoscopic images in real-time to help medical professionals detect abnormal lesions during gastroscopic and colonoscopic procedures. This software is designed to be compatible with a wide range of existing endoscopy equipment from major manufacturers like Olympus, Fuji, and Pentax, which gives it a significant advantage over competitors whose software is often limited to specific hardware. WAYMED Endo can operate without an internet connection and analyzes video feeds to identify suspicious areas, providing information on the probability of gastric cancer and improving diagnostic accuracy. The product has received clearance in South Korea and was designated as the 37th innovative medical device by the Korean Food and Drug Administration.
Waycen's business model involves supplying its software to medical institutions. The company has established a presence in its native South Korea and is actively expanding internationally, particularly in the Middle East and Southeast Asia. Strategic sales agreements have been signed with partners like MegaMind in Saudi Arabia to introduce WAYMED Endo to hospitals in the region. Waycen has also installed its software in hospitals in Vietnam, Thailand, and Cambodia. In addition to WAYMED Endo, Waycen has developed WAYMED Cough, an AI-based mobile app for self-screening respiratory health, and WAYMED EBUS, a solution that analyzes endobronchial ultrasound images to check for lung cancer metastasis. The company has received multiple CES Innovation Awards for its products and aims for a KOSDAQ listing in 2025.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Seoul, South Korea
- Employees
- 25
- Open positions
- None listed
- Dealroom signal
- 71.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Oncology, Gastroenterology, Medical Imaging, AI for medical imaging, DT and LS, science-based
- Technology
- Deep Tech
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Oct 2024 | $11M | $46M | SparkLabs Korea | ↗ |
| SERIES A✓Equity / VC | Jun 2021 | $2.3M | $9.2M | Undisclosed | — |
Growth signals
Latest recorded traffic for Waycen is 3.6K monthly website visits, up 5.9% over the last three months. Waycen's team declined 3.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 BeamWorksAI-powered medical imaging for real-time cancer diagnosis |
Daegu, South Korea | Operational | 12 | $13M | $50M |
 Micro InnoAI-supported gynecological imaging for women's reproductive health |
Hangzhou, China | Operational | |||
 BeSoundAI-powered breast imaging platform for early detection |
San Francisco, United States | Operational | |||
 AlphaGrid HealthAI-powered digital twins for precision cancer care |
Singapore | Operational | |||
 PredicTx HealthAI-powered precision health stratification platform using 3D body composition analysis from CT & MRI scans for oncology |
Melbourne, Australia | Operational | |||
 Prothea TechnologiesA New Vision for Lung Cancer Treatment |
Edinburgh, United Kingdom | Operational | |||
 Hangzhou Medical Policy TechnologyAI-powered digital pathology solutions for cancer diagnosis |
China | Operational | |||
 PCaVisionAI-powered ultrasound software for prostate cancer diagnosis. |
's-Hertogenbosch, Netherlands | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
InfoBank
Series A1 investor entered at this stage
SparkLabs Korea
Other known investors1 additional known investor
Nvidia Inception
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Waycen on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Waycen’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.